Asian Spectator


The Times

.

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

Another significant step towards the success of ICVAX®

HONG KONG SAR - Media OutReach Newswire - 27 May 2026 - Immuno Cure Group ("Immuno Cure"), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine ("ICVAX®") at the Center of International Innovation for Technology and Science ("CIITS") located in Hetao, Shenzhen.

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-librarytelegram下载matbetgrandpashabet giriş güncel girişgrandpashabet en çok kazandiran oyunskorbettelegram webjojobet güncelroyalbet girişjojobetjojobetkingroyaldeneme bonusumeritkingagen bolajojobetjojobetjojobetjojobetnakitbahis